Kyverna Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing innovative cell therapies aimed at treating autoimmune diseases. With a patient-centered approach, Kyverna leverages cutting-edge biotechnology to create effective treatments that address the complex challenges faced by individuals battling these conditions.
Massachusetts, • United States
Basel-City, • Switzerland
California, • United States
New York, • United States
Pennsylvania, • United States
California, • United States
British Columbia, • Canada
New York, • United States